Adverse Events After Stereotactic Radiotherapy and Biological Cancer Therapy

Full Article URL: <a target="_blank" href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843878">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843878
Textarea URL (this page): <a href="https://textarea.nl/i/eNrLKCkpKLbS189KzE3MSy0pzy_K1kvOz9XPyi8tykvMKUaWyC9IzdNPK83JSSwqyUzOSdU3sjAxtjC3AACONRlq_2026-01-14">https://textarea.nl/i/eNrLKCkpKLbS189KzE3MSy0pzy_K1kvOz9XPyi8tykvMKUaWyC9IzdNPK83JSSwqyUzOSdU3sjAxtjC3AACONRlq_2026-01-14
Source: https://jamanetwork.com/rss/site_214/187.xml
Jamanetwork.com Open: https://jamanetwork.com/journals/jamanetworkopen
Publication date: 2026-01-14 00:00:00
Last retrieval: 2026-01-15 06:45:31.276379

00:00 - 14 Jan 2026

This cohort study examines adverse events associated with stereotactic radiotherapy combined with concurrent biological cancer therapy in patients with metastatic or oligometastatic cancer.